source Post navigation Biolexis Therapeutics launches subsidiary Metabolexis to develop novel oral medicines for Obesity and Type 2 Diabetes to improve human longevity – Yahoo Finance PROF. DOUGLAS A. MELTON, WINNER OF THE III EDITION OF … – InvestorsObserver